ENDPOINTS

AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China

AstraZeneca is again boosting its manufacturing footprint in China, this time making a $2.5 billion investment to build its first vaccine plant and second R&D facility in the country. As a part of the investment ...

Mar 21, 2025 - 16:35
 0
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China
AstraZeneca is again boosting its manufacturing footprint in China, this time making a $2.5 billion investment to build its first vaccine plant and second R&D facility in the country. As a part of the investment ...
Read More

Tags:

Previous Article

NASA to Cover Northrop Grumman’s 21st Cargo Space Station Departure

Next Article

FDA approves Novartis’ Fabhalta in C3 glomerulopathy

Related Posts

Jazz to buy Chimerix for $935M to get brain tumor drug five months ahead of PDUFA

Jazz to buy Chimerix for $935M to get brain tumor drug ...

Mar 5, 2025  0

Merck diversity leader to retire this summer; Geron seeks commercial chops for next CEO

Merck diversity leader to retire this summer; Geron see...

Mar 14, 2025  0

Swiss biotech ends Phase 2 study in Alzheimer's shortly after Lilly and Biogen did the same

Swiss biotech ends Phase 2 study in Alzheimer's shortly...

Mar 4, 2025  0